72. Pituitary ADH secretion disorder Clinical trials / Disease details

Clinical trials : 41 / Drugs : 27 - (DrugBank : 8) / Drug target genes : 7 - Drug target pathways : 10

6 trials found

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-007941-10-BE (EUCTR)	10/09/2008	02/07/2008	A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	Dilutional hyponatraemia. MedRA term HYPONATRAEMIA MedDRA version: 10.1;Level: LLT;Classification co ...	Product Name: satavaptan Product Code: SR121463B INN or Proposed INN: satavaptan Product Name: satavapt ...	sanofi-aventis recherche et développement	NULL	Not Recruiting			Female: yes Male: yes	129		France;Hungary;Belgium;Germany
2	EUCTR2007-007941-10-HU (EUCTR)	04/08/2008	12/06/2008		A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	Dilutional hyponatraemia. MedRA term HYPONATRAEMIA MedDRA version: 9.1;Level: LLT;Classification cod ...	Product Name: satavaptan Product Code: SR121463B INN or Proposed INN: satavaptan Product Name: satavapt ...	sanofi-aventis recherche et développement	NULL	Not Recruiting			Female: yes Male: yes	129		Hungary;Germany;Belgium;France
3	NCT00728091 (ClinicalTrials.gov)	July 2008	31/7/2008	A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With D ...	A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	Hyponatremia;Inappropriate ADH Syndrome	Drug: satavaptan (SR121463);Drug: placebo	Sanofi	NULL	Terminated	18 Years	N/A	Both	2	Phase 3	United States
4	EUCTR2007-007941-10-FR (EUCTR)	16/06/2008	15/04/2008	A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	Dilutional hyponatraemia. MedRA term HYPONATRAEMIA MedDRA version: 10.1;Level: LLT;Classification co ...	Product Name: satavaptan Product Code: SR121463B INN or Proposed INN: satavaptan Product Name: satavapt ...	sanofi-aventis recherche et développement	NULL	Not Recruiting			Female: yes Male: yes	129	Phase 3	France;Hungary;Belgium;Germany
5	EUCTR2007-007941-10-DE (EUCTR)	11/06/2008	02/04/2008		A Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety ...	Dilutional hyponatraemia. MedRA term HYPONATRAEMIA MedDRA version: 10.1;Level: LLT;Classification co ...	Product Name: satavaptan Product Code: SR121463B INN or Proposed INN: satavaptan Product Name: satavapt ...	sanofi-aventis recherche et développement	NULL	Not Recruiting			Female: yes Male: yes	129		Hungary;Germany;Belgium;France
6	NCT00032734 (ClinicalTrials.gov)	June 2001	29/3/2002	Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Escalation, Multicenter Study E ...	Syndrome of Inappropriate ADH (SIADH) Secretion;Hyponatremia	Drug: satavaptan (SR121463B)	Sanofi	NULL	Completed	18 Years	N/A	Both	35	Phase 2	Belgium;France;Germany;Hungary;United States;Canada

First Previous1Next Last